Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 6 | $83,414 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 06 Mar 2025 16:26 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 04 Mar 2025 | Sale | 3,587 | 6.29 | 22,562 | D |
| 23 Apr 2024 16:02 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 22 Apr 2024 | Sale | 6,789 | 1.17 | 7,943 | D |
| 04 Mar 2024 19:41 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 01 Mar 2024 | Sale | 5,969 | 1.2 | 7,163 | D |
| 04 Mar 2024 19:41 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 29 Feb 2024 | Sale | 15,667 | 1.17 | 18,330 | D |
| 24 Apr 2023 18:09 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 20 Apr 2023 | Sale | 6,655 | 4.05 | 26,953 | D |
| 24 Apr 2023 18:09 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 20 Apr 2023 | Sale | 115 | 4.0267 | 463 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)